Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05980598
Title TransCon (TC) TLR7/8 Agonist, TC IL-2 beta/gamma, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201)
Acronym BelieveIT-201
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ascendis Pharma Oncology Division A/S
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP | DEU

Facility Status City State Zip Country Details
Ascendis Investigational Site RECRUITING Los Angeles California 90067 United States Details
Ascendis Investigational Site RECRUITING San Francisco California 94158 United States Details
Ascendis Investigational Site RECRUITING Louisville Kentucky 40202 United States Details
Ascendis Investigational Site RECRUITING Detroit Michigan 48201 United States Details
Ascendis Investigational Site RECRUITING New York New York 11794 United States Details
Ascendis Pharma Investigational Site RECRUITING Canton Ohio 44718 United States Details
Ascendis Investigational Site RECRUITING Cincinnati Ohio 45219 United States Details
Ascendis Investigational Site RECRUITING Charleston South Carolina 29425 United States Details
Ascendis Investigational Site RECRUITING Knoxville Tennessee 37902 United States Details
Ascendis Investigational Site RECRUITING Houston Texas 77030 United States Details
Ascendis Investigational Site RECRUITING Kutaisi Imereti 4600 Georgia Details
Ascendis Investigational Site RECRUITING Tbilisi 0114 Georgia Details
Ascendis Investigational Site RECRUITING Tbilisi 0144 Georgia Details
Ascendis Investigational Site II RECRUITING Tbilisi 0159 Georgia Details
Ascendis Investigational Site RECRUITING Tbilisi 0159 Georgia Details
Ascendis Investigational Site RECRUITING Tbilisi 0186 Georgia Details
Ascendis Investigational Site RECRUITING Erlangen Bavaria 91054 Germany Details
Ascendis Investigational Site RECRUITING Mannheim 68167 Germany Details
Ascendis Investigational Site RECRUITING Pécs Baranya 7624 Hungary Details
Ascendis Investigational Site RECRUITING Budapest 1122 Hungary Details
Ascendis Investigational Site RECRUITING Debrecen 4032 Hungary Details
Ascendis Investigational Site RECRUITING Győr 9024 Hungary Details
Ascendis Investigational Site RECRUITING Meldola 47014 Italy Details
Ascendis Investigational Site RECRUITING Milan 20133 Italy Details
Ascendis Investigational Site RECRUITING Naples 80131 Italy Details
Ascendis Investigational Site RECRUITING Novara 28100 Italy Details
Ascendis Investigational Site RECRUITING Rozzano 20089 Italy Details
Ascendis Investigational Site RECRUITING Warszawa 02-781 Poland Details
Ascendis Investigational Site RECRUITING Barcelona 08003 Spain Details
Ascendis Investigational Site RECRUITING Barcelona 08035 Spain Details
Ascendis Investigational Site RECRUITING El Palmar 30120 Spain Details
Ascendis Investigational Site RECRUITING L'Hospitalet De Llobregat 08908 Spain Details
Ascendis Investigational Site RECRUITING Madrid 28027 Spain Details
Ascendis Investigational Site II RECRUITING Madrid 28040 Spain Details
Ascendis Investigational Site RECRUITING Madrid 28040 Spain Details
Ascendis Investigational Site RECRUITING Madrid 28050 Spain Details
Ascendis Investigational Site RECRUITING Málaga 29011 Spain Details
Ascendis Investigational Site RECRUITING Pamplona 31008 Spain Details
Ascendis Investigational Site RECRUITING Terrassa 08221 Spain Details
Ascendis Investigational Site RECRUITING Valencia 46009 Spain Details
Ascendis Investigational Site RECRUITING Valencia 46014 Spain Details
Ascendis Investigational Site RECRUITING Valencia 46026 Spain Details
Ascendis Investigational Site RECRUITING Zaragoza 50009 Spain Details
Ascendis Investigational Site RECRUITING Kaohsiung City 80708 Taiwan Details
Ascendis Investigational Site RECRUITING Taoyuan 333 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field